PRISM BioLab and Receptor.AI Partner for AI Drug Discovery
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
Alzheimer’s Disease Animal Health Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cell Therapy cGxP cGxP compliance Clinical-Stage Biotech Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy GMP compliance Immuno-Oncology immunology Immunotherapy Johnson & Johnson Medical Devices MedTech medtech innovation Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine Regulatory Affairs regulatory approval regulatory compliance Sanofi targeted therapy
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
LA JOLLA, Calif., March 13, 2026 Equillium Inc., a biotechnology company developing novel therapies for severe autoimmune and inflammatory...
NORWELL, Mass., and MIAMI, Fla., March 12, 2026 The National Organization for Rare Disorders (NORD) and OpenEvidence have announced...
SINGAPORE, March 12, 2026 Emerald Clinical Trials, a leading global clinical research organization (CRO), has been honored with the...
LONDON, UK, March 11, 2026 George Medicines, a late-stage biopharmaceutical company focused on cardiometabolic diseases, has announced an exclusive...
LANGHORNE, Pa., March 12, 2026 NEXGEL, Inc. has announced the consideration terms of an agreement to license and acquire...
SAN JOSE, Calif., March 12, 2026 PROCEPT BioRobotics has announced the international launch of its HYDROS® Robotic System, a...
CAMBRIDGE, Mass., March 11, 2026 Vima Therapeutics has announced a major milestone in its drug development pipeline, confirming that...
KING OF PRUSSIA, Pa., March 9, 2026 CSL Limited, a global biopharmaceutical leader, has announced a $1.5 billion investment...
SILVER SPRING, Md., March 11, 2026 The U.S. Food and Drug Administration (FDA) has launched a new unified safety...
